Politics

Politics

House progressives plot overhaul of Pelosi drug pricing bill

By Lev Facher and Nicholas Florko

Pharmalot

A small biotech raises the price on its cancer drug by 20% this year, but will anyone notice?

By Ed Silverman

Politics

With a new lobbying group and a day at the White House, synthetic biology looks for footing in Washington

By Nicholas Florko and Rebecca Robbins

Politics

Buttigieg’s balancing act: He wants far lower drug prices even as he hopes the drug industry will ‘thrive’

By Nicholas Florko

Politics

Buttigieg unveils an aggressive plan for lowering drug prices

By Nicholas Florko and Lev Facher

Politics

‘It shows how much pharma has on their plate’: Congress just quietly passed a bill that will cost drug makers $3 billion

By Nicholas Florko

Politics

An unconventional health care speech: Trump wishes pharma stocks would drop, and implies drug industry is behind impeachment

By Nicholas Florko

Pharmalot

White House insists drug prices are falling, but critics say its report is flawed

By Ed Silverman

Politics

Trump set to nominate Stephen Hahn as FDA commissioner, pending vetting process

By Lev Facher and Nicholas Florko

Politics

Pelosi’s drug pricing plan could wipe out some key funding for low-income hospitals

By Nicholas Florko

Politics

NIH must better protect research from foreign influence, federal watchdog says

By Lev Facher

Politics

‘Why don’t you stop talking?’ Hearing on Pelosi’s drug pricing plan mired by partisan bickering

By Nicholas Florko

Politics

The Democrats shepherding Pelosi’s drug pricing bill have taken plenty of campaign cash from pharma

By Lev Facher

Politics

Trump says it’s ‘great to see’ Pelosi’s drug pricing plan

By Lev Facher and Nicholas Florko

Politics

Our 9 biggest questions about Nancy Pelosi’s drug pricing bill

By Nicholas Florko and Lev Facher

Politics

Pelosi’s drug pricing plan would let Medicare negotiate prices for up to 250 drugs

By Lev Facher

Politics

Democrats still have questions about Nancy Pelosi’s drug pricing plan

By Lev Facher

Politics

Industry groups push back against ‘troubling’ FDA crackdown on genetic tests used to predict response to drugs

By Rebecca Robbins

Politics

With ominous TV spots and a senior ‘strike force,’ AARP launches an all-out attack on pharma

By Nicholas Florko

Politics

Couple stole trade secrets from U.S. children’s hospital to market their Chinese biotech, prosecutors say

By Lev Facher

Politics

BIO’s new board chair on the industry’s bad reputation: ‘That’s ridiculous’

By Nicholas Florko

Politics

Frontrunner to lead FDA, dogged by controversies, has developed knack for confronting them

By Lev Facher and Nicholas Florko

Politics

Pelosi’s drug pricing plan is more aggressive than expected

By Nicholas Florko and Lev Facher

President Trump - New US-Mexico-Canada Trade Deal

Politics

MD Anderson oncologist met with Trump about FDA commissioner job

By Nicholas Florko

Politics

Study: A cap on Medicare drug costs helps a small few — a lot

By Nicholas Florko

This small biotech is suing the Trump administration to get its drug covered

How Joe Grogan, a former pharma lobbyist, upended Trump’s drug pricing agenda

After 10 hours and a pile of rejected amendments, Democrats advance their drug pricing bill out of two key committees

Pelosi: Democrats will name marquee drug pricing bill for late Rep. Cummings

House progressives plot overhaul of Pelosi drug pricing bill

A small biotech raises the price on its cancer drug by 20% this year, but will anyone notice?

With a new lobbying group and a day at the White House, synthetic biology looks for footing in Washington

Buttigieg’s balancing act: He wants far lower drug prices even as he hopes the drug industry will ‘thrive’

Buttigieg unveils an aggressive plan for lowering drug prices

‘It shows how much pharma has on their plate’: Congress just quietly passed a bill that will cost drug makers $3 billion

An unconventional health care speech: Trump wishes pharma stocks would drop, and implies drug industry is behind impeachment

White House insists drug prices are falling, but critics say its report is flawed

Trump set to nominate Stephen Hahn as FDA commissioner, pending vetting process

Pelosi’s drug pricing plan could wipe out some key funding for low-income hospitals

NIH must better protect research from foreign influence, federal watchdog says

‘Why don’t you stop talking?’ Hearing on Pelosi’s drug pricing plan mired by partisan bickering

The Democrats shepherding Pelosi’s drug pricing bill have taken plenty of campaign cash from pharma

Trump says it’s ‘great to see’ Pelosi’s drug pricing plan

Our 9 biggest questions about Nancy Pelosi’s drug pricing bill

Pelosi’s drug pricing plan would let Medicare negotiate prices for up to 250 drugs

Democrats still have questions about Nancy Pelosi’s drug pricing plan

Industry groups push back against ‘troubling’ FDA crackdown on genetic tests used to predict response to drugs

With ominous TV spots and a senior ‘strike force,’ AARP launches an all-out attack on pharma

Couple stole trade secrets from U.S. children’s hospital to market their Chinese biotech, prosecutors say

BIO’s new board chair on the industry’s bad reputation: ‘That’s ridiculous’

Frontrunner to lead FDA, dogged by controversies, has developed knack for confronting them

Pelosi’s drug pricing plan is more aggressive than expected

MD Anderson oncologist met with Trump about FDA commissioner job

Study: A cap on Medicare drug costs helps a small few — a lot